ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 047,05
0,63%
Dow Jones
38 852,27
0,46%
DAX
18 255,65
0,46%
Brent Oil
83,185
-0,35%
Bitcoin
63 776,50
0,97%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX
  6. Willow Biosciences Inc (WLLW)

  7. Willow Biosciences Inc (WLLW) Actualités

WLLW

Willow Biosciences (WLLW)

Willow Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:TSX:WLLW
DateHeureSourceTitreSymboleSociété
29/03/202400h30PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIFTSX:WLLWWillow Biosciences Inc
01/03/202400h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES SECOND STRATEGIC INVESTMENT FROM KALSECTSX:WLLWWillow Biosciences Inc
21/02/202400h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES STRATEGIC INVESTMENT FROM KALSEC TO DEVELOP INNOVATIVE NATURAL FOOD INGREDIENTSTSX:WLLWWillow Biosciences Inc
31/01/202413h00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENTTSX:WLLWWillow Biosciences Inc
16/01/202413h00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH ENTERIN TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
10/01/202413h00PR Newswire (US)WILLOW PLANS FOR SIGNIFICANT GROWTH IN 2024 ON THE BACK OF A SUCCESSFUL 2023TSX:WLLWWillow Biosciences Inc
07/12/202313h00PR Newswire (US)WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY ADVANCE DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
11/10/202301h52PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMPLETION OF PREVIOUSLY ANNOUNCED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
03/10/202313h00PR Newswire (US)WILLOW AND SUANFARMA ANNOUNCE COLLABORATION ON DEVELOPMENT OF LARGE VOLUME ANTI-INFECTIVE API THROUGH PRECISION FERMENTATIONTSX:WLLWWillow Biosciences Inc
12/09/202313h00PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES COMPANY INSIDER LED CONVERTIBLE DEBENTURE FINANCINGTSX:WLLWWillow Biosciences Inc
06/09/202313h00PR Newswire (Canada)WILLOW ANNOUNCES SUCCESSFUL COMPLETION OF R&D PROGRAM ON COST-EFFECTIVE, SUSTAINABLY PRODUCED UDCATSX:WLLWWillow Biosciences Inc
30/08/202313h00PR Newswire (US)WILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTTSX:WLLWWillow Biosciences Inc
24/08/202313h00PR Newswire (US)WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND FOCUS ON BIOOXI PLATFORMTSX:WLLWWillow Biosciences Inc
21/08/202313h00PR Newswire (US)WILLOW ANNOUNCES COLLABORATION WITH A LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY TO DEVELOP SUSTAINABLE INTERMEDIATES AND ACTIVE PHARMACEUTICAL INGREDIENTSTSX:WLLWWillow Biosciences Inc
08/08/202323h10PR Newswire (US)WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSTSX:WLLWWillow Biosciences Inc
20/07/202313h00PR Newswire (US)WILLOW AND KALSEC ADVANCE DEVELOPMENT PROGRAM FOR NEW NATURAL FUNCTIONAL INGREDIENT FOR SAVORY FOODSTSX:WLLWWillow Biosciences Inc
31/05/202313h00PR Newswire (US)WILLOW SIGNS MASTER SERVICES AGREEMENT WITH INNOVATIVE BIOTECH COMPANY TO DEVELOP INGREDIENTS FOR AGE-RELATED DISEASESTSX:WLLWWillow Biosciences Inc
23/05/202313h00PR Newswire (Canada)KALSEC AND WILLOW BIOSCIENCES TO DEVELOP NOVEL ENZYME FOR PRODUCTION OF AN ADVANCED BEVERAGE INGREDIENTTSX:WLLWWillow Biosciences Inc
12/05/202323h04PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTSTSX:WLLWWillow Biosciences Inc
12/05/202302h58PR Newswire (US)WILLOW BIOSCIENCES REPORTS FIRST QUARTER 2023 RESULTSTSX:WLLWWillow Biosciences Inc
19/04/202317h35AllPennyStocks.comCommercial Agreement Sends Micro Cap SoaringTSX:WLLWWillow Biosciences Inc
18/04/202322h30PR Newswire (US)WILLOW ANNOUNCES COMMERCIAL AGREEMENT WITH SANDHILL ONETSX:WLLWWillow Biosciences Inc
12/04/202322h30PR Newswire (Canada)WILLOW ANNOUNCES ROLLOUT OF BioOxi PLATFORM PROVIDING VALUABLE AND EXPEDITED BIOCONVERSION-ENABLED CHEMICAL MANUFACTURINGTSX:WLLWWillow Biosciences Inc
28/03/202322h10PR Newswire (Canada)WILLOW BIOSCIENCES ANNOUNCES CHANGES TO BOARD AND MANAGEMENTTSX:WLLWWillow Biosciences Inc
22/03/202312h00PR Newswire (Canada)WILLOW & SUANFARMA ANNOUNCE COMPLETED DEVELOPMENT AND MANUFACTURING PROCESS FOR CBG AND COMMITMENT TO THE PRODUCTION OF NEW MOLECULES IN A NATURAL WAYTSX:WLLWWillow Biosciences Inc
21/03/202323h49PR Newswire (Canada)WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2022 FINANCIALS AND OPERATIONS AND FILING OF ITS 2022 AIFTSX:WLLWWillow Biosciences Inc
22/02/202313h00PR Newswire (US)WILLOW ANNOUNCES APPOINTMENT OF DR. JIM LALONDE TO BOARD OF DIRECTORSTSX:WLLWWillow Biosciences Inc
17/01/202313h00PR Newswire (US)WILLOW ANNOUNCES FOLLOW-ON ENGAGEMENT FOR NEXT PHASE OF PARTNERED PHARMACEUTICAL PROJECTTSX:WLLWWillow Biosciences Inc
14/12/202213h00PR Newswire (US)WILLOW PROVIDES CORPORATE UPDATES, BUSINESS OUTLOOK AND KEY TARGETED MILESTONES ANTICIPATED FOR 2023 TO EXPAND GROWTHTSX:WLLWWillow Biosciences Inc
07/12/202213h00PR Newswire (US)WILLOW FURTHER OPTIMIZES ITS BUSINESS TO FOCUS ON NEAR-TERM REVENUE GENERATION AND REDUCE CASH BURNTSX:WLLWWillow Biosciences Inc
 Showing the most relevant articles for your search:TSX:WLLW

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
BEL20
Bel 20
SPI
SP500
S&P 500
NASDAQ
MSFT
Microsoft
EU
GLE
Societe Generale
EU
CS
Axa
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
EU
BN
Danone
COIN
BTCUSD
Bitcoin
EU
ORA
Orange
EU
VIV
Vivendi
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
MRK
Merck
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés